Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Baclofen Hydrochloride. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102351726B reveals a novel Baclofen route using ultrafine potassium carbonate. Achieve cost reduction in API manufacturing with high-purity pharmaceutical intermediates.
Patent CN102351726A reveals a high-yield baclofen intermediate synthesis using ultrafine potassium carbonate, eliminating toxic solvents and cryogenic conditions for cost-effective manufacturing.